Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
H3Africa Consortium | RCV001777132 | SCV002014628 | benign | not specified | 2020-10-28 | criteria provided, single submitter | research | While the frequency of the alternate allele in gnoMAD v2.0.2 is 0.229, its frequency in African populations is >5%. This suggests that previous classifications of this variant as pathogenic are in error. |
Labcorp Genetics |
RCV002054421 | SCV002489735 | benign | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002490325 | SCV002799026 | benign | Hereditary cerebral amyloid angiopathy, Icelandic type; Age related macular degeneration 11 | 2021-08-10 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV002054421 | SCV005314930 | benign | not provided | criteria provided, single submitter | not provided | ||
OMIM | RCV000005989 | SCV000026171 | pathogenic | Age related macular degeneration 11 | 2002-02-01 | no assertion criteria provided | literature only | |
Reproductive Health Research and Development, |
RCV000005989 | SCV001142496 | benign | Age related macular degeneration 11 | 2020-01-06 | no assertion criteria provided | curation | NM_000099.2:c.73G>A in the gene CST3 has an allele frequency of 0.297 in South Asian subpopulation in the gnomAD database. A total of 3515 homozygous occurrences are observed in the gnomAD database. This evidence suggests the variant to be classified as benign. ACMG/AMP criteria applied: BA1; BS2. |